Myotonic Dystrophy type 2 (DM2)
Definition
It results from expansion of the CCTG tetranucleotide repeat in intron 1 of the CNBP (ZNF9) gene. This autosomal dominant multisystem disease presents with progressive proximal muscle weakness, myotonia, myalgia, calf hypertrophy, cataracts, and endocrine involvement; it is generally milder than DM1.
Gene/region examined
CNBP - CCTG Repeat Number Analysis
Method
Fragment Analysis
Accepted sample types
EDTA blood, AF, CVS
Inheritance
Hereditary, autosomal dominant.